(self.webpackChunk_N_E=self.webpackChunk_N_E||[]).push([[404],{827:e=>{e.exports={map:"CustomMap_map__mS_Y9",overlay:"CustomMap_overlay__8z0Jm"}},4622:(e,t,r)=>{"use strict";r.d(t,{K:()=>l});var a=r(95155),s=r(75196);let l=e=>{let{backgroundImage:t}=e;return(0,a.jsx)("div",{className:"bg-primary relative h-96 w-full overflow-hidden 2xl:h-[40rem]",children:(0,a.jsx)(s.P.img,{src:t||"/images/clinical-trials-hero-banner.jpg",className:"absolute inset-0 mx-auto h-full w-full object-cover object-[50%_40%]"})})}},25002:(e,t,r)=>{"use strict";r.d(t,{Wh:()=>m,my:()=>h});var a=r(95155),s=r(6874),l=r.n(s),n=r(84873),i=r(48539),c=r(59434),o=r(58816),d=r(58098);let m=e=>{let{status:t,...r}=e;return(0,a.jsx)(n.E,{variant:(()=>{switch(t){case"COMPLETED":return"tertiary";case"ACTIVE_NOT_RECRUITING":return"muted";case"RECRUITING":return"accent";default:return"outline"}})(),size:"sm",...r,children:(e=>"ACTIVE_NOT_RECRUITING"===e?"Not Recruiting":e.toLowerCase().split("_").map(e=>e.charAt(0).toUpperCase()+e.slice(1)).join(" "))(t)})},h=()=>{let{markers:e}=(0,o.J)(),t=e.map(e=>e.acronym.toLowerCase()),r=Object.values(d).filter(e=>t.includes(e.acronym.toLowerCase()));return 0===r.length?(0,a.jsx)("div",{className:"w-full p-8 text-center",children:(0,a.jsx)("p",{children:"No clinical trials found."})}):(0,a.jsx)("div",{className:"@container w-full bg-white",children:(0,a.jsxs)("div",{className:"@tablet:grid @tablet:grid-cols-[min-content_1fr_1fr_minmax(150px, auto)_minmax(150px, auto)]",children:[(0,a.jsx)("div",{className:"bg-primary text-primary-foreground @tablet:text-xl @tablet:grid col-span-5 hidden grid-cols-subgrid gap-x-3 px-3 py-3 text-lg font-medium",children:["Type of Cancer","Trial Description","Select Eligibility Criteria","Status","For More Information"].map(e=>(0,a.jsxs)("div",{style:{textAlign:e.startsWith("Status")?"center":"left"},children:[e,e.startsWith("Select ")?(0,a.jsx)("sup",{children:"a"}):null,e.startsWith("Status")?(0,a.jsxs)("p",{className:"mt-2 mb-0! max-w-[10rem] text-center text-[0.8rem] leading-4 text-white",children:["Recruitment status may vary by trial site",(0,a.jsx)("sup",{children:"b"})]}):null]},e))}),(0,a.jsx)(a.Fragment,{children:r.map((e,t,r)=>{let s=t>0?r[t-1]:null,n=e.cancerTypeTable===(null==s?void 0:s.cancerTypeTable);return(0,a.jsxs)("div",{className:(0,c.cn)("@tablet:col-span-5 @tablet:grid-cols-subgrid border-accent @tablet:border-b-0 hover:bg-muted hover:text-muted-foreground grid grid-cols-1 gap-x-3 border-b px-3 py-6 transition-colors duration-300",!n&&"border-t"),children:[(0,a.jsxs)("div",{className:(0,c.cn)("@tablet:text-base text-sm break-words"),children:[(0,a.jsx)("p",{className:"@tablet:hidden text-foreground mt-[2rem]! mb-[1rem]! block p-0 font-bold",children:"Type of cancer"}),(0,a.jsx)("div",{className:"@tablet:block hidden",children:n?null:(0,a.jsx)(i.T,{as:"p",className:"font-[900]!",children:e.cancerTypeTable})}),(0,a.jsx)("div",{className:"@tablet:hidden block",children:(0,a.jsx)(i.T,{as:"p",children:e.cancerTypeTable})})]}),(0,a.jsxs)("div",{className:"@tablet:text-base space-y-2 text-sm break-words",children:[(0,a.jsx)("p",{className:"@tablet:hidden text-foreground mb-[1rem]! block p-0 font-bold",children:"Trial Description"}),(0,a.jsx)(i.T,{as:"p",children:String(e.descriptionTable)})]}),(0,a.jsxs)("div",{className:"@tablet:text-base text-sm break-words",children:[(0,a.jsxs)("p",{className:"@tablet:hidden text-foreground mb-[1rem]! block p-0 font-bold",children:["Select Eligibility Criteria:"," "]}),(0,a.jsx)(i.T,{children:String(e.selectedEligibilityCriteriaTable)})]}),(0,a.jsxs)("div",{className:"@tablet:text-base text-sm break-words",children:[(0,a.jsxs)("p",{className:"@tablet:hidden text-foreground mb-[1rem]! block p-0 font-bold",children:["Status:",(0,a.jsx)("br",{})," ",(0,a.jsxs)("span",{className:"text-sm font-normal",children:["(Recruitment status may vary by trial site",(0,a.jsx)("sup",{children:"b"})]}),")"]}),(0,a.jsx)("div",{children:(0,a.jsx)("div",{className:"bg-secondary rounded-[1rem] px-[1rem] py-[0.25rem] text-center text-xs text-white capitalize",children:(0,a.jsx)("p",{className:"mb-0! text-sm text-white",children:e.statusTable})})})]}),(0,a.jsxs)("div",{className:"@tablet:text-base text-sm break-words",children:[(0,a.jsxs)("p",{className:"@tablet:hidden text-foreground mt-[3rem] mb-[1rem]! block p-0 font-bold",children:["For more information:"," "]}),(0,a.jsx)(l(),{href:"/clinical-trials/".concat(e.nctId.toLowerCase()),passHref:!0,children:(0,a.jsx)(i.T,{as:"p",className:"text-haze-green font-bold underline underline-offset-3",children:e.nctId})})]})]},e.nctId)})})]})})}},38450:(e,t,r)=>{Promise.resolve().then(r.bind(r,51944))},51944:(e,t,r)=>{"use strict";r.r(t),r.d(t,{default:()=>T});var a=r(95155),s=r(12115),l=r(25002),n=r(75196),i=r(45084),c=r(66766),o=r(19988),d=r(58816),m=r(827),h=r.n(m);let u=(0,s.memo)(function(){return(0,a.jsx)(o.c4,{apiKey:"AIzaSyDpFbgtC510BQbyHW-fe6CuGvpoTOifG8I",children:(0,a.jsx)(()=>{let e=(0,o.ko)(),{markers:t,selectedMarker:r,setSelectedMarker:l,filters:m,clearFilters:u}=(0,d.J)(),x={},b=0;t.forEach(e=>{x.hasOwnProperty(e.country)?(m.state&&m.state.length?(m.state.forEach(t=>{e.state.includes(t)&&(b+=e.locations)}),x[e.country].locations=b,b=0):x[e.country].locations=x[e.country].locations+e.locations,x[e.country].trials.push({acronym:e.acronym,nct:e.nct,tumor:e.tumor})):x[e.country]={locations:e.locations,trials:[{acronym:e.acronym,nct:e.nct,tumor:e.tumor}],latLon:e.latLon}});let p=t=>{let{marker:r,selectMarker:l,country:n}=t,[i,d]=(0,o.vH)(),m=(0,s.useCallback)(()=>{l({...r,country:n}),e.setCenter({lat:Number(r.latLon[0]),lng:Number(r.latLon[1])})},[]);return(0,a.jsx)(o.J8,{ref:i,position:{lat:Number(r.latLon[0]),lng:Number(r.latLon[1])},onClick:m,children:(0,a.jsxs)("div",{style:{display:"flex",flexDirection:"column",justifyContent:"center",alignItems:"center"},children:[(0,a.jsx)("div",{style:{borderRadius:"2rem",backgroundColor:"#234b43",paddingLeft:"1rem",paddingRight:"1rem",color:"white",marginBottom:"0.25rem"}}),(0,a.jsx)(c.default,{src:"/images/RVM-Marker.png",width:72,height:72,alt:"map marker"})]})},"".concat(r.latLon[0],"_").concat(r.latLon[1]))};return(0,s.useEffect)(()=>{if(!e)return;let r=new window.google.maps.LatLngBounds;t.map(e=>r.extend({lat:Number(e.latLon[0]),lng:Number(e.latLon[1])})),e.fitBounds(r)},[t,e]),(0,a.jsxs)("div",{className:"relative bg-white",children:[t.length?null:(0,a.jsxs)("div",{className:h().overlay,children:[(0,a.jsx)("h1",{className:"text-center text-[#0e4343]",children:"No locations found for your selected filters"}),(0,a.jsxs)("p",{className:"text-center text-[#0e4343]",onClick:()=>u(),children:["Please select new filters or"," ",(0,a.jsx)("span",{className:"cursor-pointer underline",children:"clear current filters"})]})]}),(0,a.jsxs)(o.T5,{disableDefaultUI:!1,defaultCenter:{lat:51.50710667223679,lng:-.15656673728509093},maxZoom:5,defaultZoom:10,mapId:"DEMO_MAP_ID",className:h().map,gestureHandling:"cooperative",children:[Object.keys(x).map((e,t)=>x[e].latLon.length>1?(0,a.jsx)(p,{marker:x[e],country:e,selectMarker:l},"".concat(t)):null),(0,a.jsx)(i.N,{children:r?(0,a.jsx)(e=>{let{selectedMarker:t}=e,r=(()=>{let e=t.trials,r={};return e.forEach(e=>{r.hasOwnProperty(e.tumor)?r[e.tumor].push({...e}):r[e.tumor]=[e]}),r})(t);if(m.tumor.length){let e=[];Object.keys(r).map(t=>{m.tumor.includes(t)||e.push(t)}),e.forEach(e=>delete r[e])}return(0,a.jsx)(n.P.div,{initial:{opacity:0,translateX:"-25%"},animate:{opacity:1,translateX:"0"},transition:{ease:"easeOut",duration:.25},exit:{opacity:0,translateX:"-25%"},className:"absolute top-0 h-full w-[25%] min-w-[15rem] overflow-y-auto drop-shadow-2xl",children:(0,a.jsxs)("div",{className:"flex min-h-full flex-col justify-center bg-white p-4",children:[(0,a.jsx)("button",{className:"absolute top-0 right-0 cursor-pointer p-4",onClick:()=>{l(!1)},children:(0,a.jsx)(c.default,{src:"./close_24dp_0E4343_FILL0_wght400_GRAD0_opsz24.svg",height:30,width:30,alt:"map marker"})}),(0,a.jsx)("p",{className:"text-md m-0! mt-4",children:"Trials in:"}),(0,a.jsx)("p",{className:"text-2xl font-bold underline",children:t.country}),Object.keys(r).map(e=>(0,a.jsxs)(s.Fragment,{children:[(0,a.jsx)("p",{className:"text-md m-0! mb-[1rem]! font-bold",children:e}),(0,a.jsx)("ul",{children:r[e].map(e=>(0,a.jsx)("li",{children:(0,a.jsx)("a",{href:"https://clinicaltrials.gov/study/".concat(e.nct),target:"_blank",children:(0,a.jsxs)("div",{className:"mb-[1rem] flex flex-row items-center justify-between hover:underline",children:[(0,a.jsx)("p",{className:"m-0!",children:e.acronym}),(0,a.jsx)(c.default,{height:100,width:100,alt:"map marker",className:"w-[1.5rem]",src:"open_in_new_24dp_234B43_FILL0_wght400_GRAD0_opsz24.svg"})]})})},e.nct))})]},e))]})})},{selectedMarker:r}):null})]})]})},{})})});var x=r(70248),b=r(4622),p=r(65125),g=r(27698),f=r(48458),j=r(63119),v=r.n(j);let w=e=>{let{label:t,items:r,action:l,controlledOptions:n,disabled:i}=e,[c,o]=(0,s.useState)(!1);return(0,a.jsxs)(g.bL,{onOpenChange:o,modal:!1,children:[(0,a.jsx)(g.l9,{asChild:!0,disabled:i,children:(0,a.jsxs)("button",{disabled:i,className:"".concat(v()["input-button"]," ").concat(i?v()["input-button-disabled"]:""),"aria-label":"select ".concat(t),children:[(0,a.jsxs)("div",{children:[t," ",n&&n.length?"(".concat(n.length,")"):""]}),(0,a.jsx)("div",{children:c?(0,a.jsx)("img",{src:"./keyboard_arrow_up_24dp_FFFFFF_FILL0_wght400_GRAD0_opsz24.svg"}):(0,a.jsx)("img",{src:"./keyboard_arrow_down_24dp_FFFFFF_FILL0_wght400_GRAD0_opsz24.svg"})})]})}),(0,a.jsx)(g.ZL,{children:(0,a.jsx)(g.UC,{className:v()["dropdown-context"],sideOffset:5,children:r?r.map(e=>(0,a.jsxs)("div",{className:v()["checkbox-container"],style:{backgroundColor:n&&n.length?n.includes(e)?"white":"lightgray":"white"},children:[(0,a.jsx)(f.bL,{className:v().checkbox,id:e,onCheckedChange:r=>l(t,e,r),checked:!!(n&&n.includes(e)),onClick:()=>{n&&!n.includes(e)&&(0,p.sendGAEvent)("event","filterSelectionString",{filterSelectionString:"".concat(t,"-").concat(e)})},children:(0,a.jsx)(f.C1,{className:"CheckboxIndicator",children:(0,a.jsx)("img",{src:"./check_24dp_234B43_FILL0_wght400_GRAD0_opsz24.svg"})})}),(0,a.jsx)("label",{className:v()["checkbox-label"],htmlFor:e,children:e})]},e)):null})})]})};var y=r(54283),N=r(92553),_=r.n(N);let k=()=>{let{allFilters:e,setFunctions:t,clearFilters:r,filters:s,markers:l}=(0,d.J)(),n=[...new Set(Object.keys(s).map(e=>s[e]))].flat(),i=[...new Set(l.map(e=>e.acronym))];return(0,a.jsxs)("div",{className:"mb-8",children:[(0,a.jsxs)("div",{className:_().container,children:[(0,a.jsx)("div",{children:Object.keys(e).map(r=>(0,a.jsx)(w,{label:r,items:e[r],action:t[r],controlledOptions:s[r],disabled:"state"===r&&!(s.country.length&&s.country.includes("United States"))},r))}),(0,a.jsxs)("button",{className:_().button,onClick:()=>r(),children:["clear\xa0all",(0,a.jsx)("img",{src:"./close_24dp_FFFFFF_FILL0_wght400_GRAD0_opsz24.svg"})]})]}),n.length?(0,a.jsxs)(a.Fragment,{children:[(0,a.jsx)("div",{className:"flex justify-between",children:(0,a.jsxs)("p",{className:"mt-10",children:["Showing ",i.length," trials with selected filters"]})}),(0,a.jsx)("div",{className:"flex flex-col gap-2",children:Object.keys(s).sort().map(e=>s[e].length?(0,a.jsxs)(a.Fragment,{children:[(0,a.jsxs)("div",{className:"flex items-center gap-2",children:[(0,a.jsx)("p",{className:"m-0! min-w-[6rem] text-sm capitalize",children:e}),(0,a.jsx)("div",{className:"flex flex-col gap-2",children:s[e].map(r=>(0,a.jsxs)("div",{onClick:()=>t[e](e,r,!1),className:"bg-secondary flex w-fit cursor-pointer items-center justify-between rounded-2xl px-4 py-1",children:[(0,a.jsxs)("div",{children:[(0,a.jsx)("p",{className:"m-0! text-sm leading-4 text-white",children:r})," "]}),(0,a.jsx)("div",{className:"aspect-square h-5 w-5 translate-x-3 rounded-full bg-white",children:(0,a.jsx)("img",{src:"./close_24dp_000000_FILL0_wght400_GRAD0_opsz24.svg"})})]},r))})]},e),(0,a.jsx)("div",{className:"h-[0.1rem] w-full bg-black/10"})]}):null)})]}):(0,a.jsxs)(a.Fragment,{children:[(0,a.jsx)(y.c,{marginTop:!0}),(0,a.jsx)("p",{className:"mt-10 mb-0!",children:"Showing all trials"})]})]})};var C=r(59434),R=r(58098);let S=e=>{let{href:t,children:r,className:s}=e;return(0,a.jsx)("a",{target:"_blank",rel:"noopener noreferrer",href:t,className:(0,C.cn)(s),children:r})},T=()=>{let{markers:e}=(0,d.J)(),t=[...new Set(e.map(e=>e.acronym))];return Object.keys(R).length,t.length,(0,a.jsxs)(x.B.Root,{children:[(0,a.jsx)(x.B.Item.Root,{bleed:"full",children:(0,a.jsx)(x.B.Item.Subgrid,{xGridSpan:"full",children:(0,a.jsx)(b.K,{})})}),(0,a.jsx)(x.B.Item.Root,{bleed:"none",className:"bg-primary",bottomBump:{foregroundColor:"bg-primary",backgroundColor:"bg-muted",rounded:"bottom-left"},children:(0,a.jsx)(x.B.Item.Subgrid,{xGridSpan:"full",children:(0,a.jsx)("h1",{className:"mt-[3rem] mb-0!",children:"Clinical Trials"})})}),(0,a.jsx)(x.B.Item.Root,{id:"select-clinical-trials",bleed:"none",background:(0,a.jsx)("div",{className:"bg-muted h-full w-full"}),className:"bg-muted pt-12",bottomBump:{foregroundColor:"bg-muted",backgroundColor:"bg-[#f5f8f9]!",rounded:"bottom-left"},children:(0,a.jsx)(x.B.Item.Subgrid,{xGridSpan:"full",animation:"staggerItem",className:"bg-muted text-muted-foreground",children:(0,a.jsxs)("div",{className:"flex w-full flex-col gap-4",children:[(0,a.jsxs)("h2",{children:["Select Clinical Trials"," ",(0,a.jsx)("span",{className:"text-[]",children:"of RAS(ON) Inhibitors"})]}),(0,a.jsx)("p",{children:"At Revolution Medicines we are committed to the discovery, development, and delivery of targeted therapies for patients with RAS mutant cancer. Our RAS(ON) Inhibitor Clinical Trial Program is evaluating molecules aimed at targeting a broad range of RAS mutant cancers. Rat sarcoma (RAS) is a protein that is important in regulating cell division in our bodies. In certain cancers known as RAS mutant cancers, changes (or mutations) in the RAS gene cause the RAS protein to become mostly switched ON (or active), allowing the cancer cells to grow, spread, and survive."}),(0,a.jsx)("h3",{children:"Investigational RAS(ON) inhibitors currently under development include:"}),(0,a.jsxs)("ul",{className:"max-w-[55rem]",children:[(0,a.jsxs)("li",{children:[(0,a.jsx)("b",{children:"Daraxonrasib (RMC-6236)"}),', an oral, RAS(ON) multi-selective inhibitor that is selective for the active or "(ON)" state of multiple mutant forms of RAS (G12X, G13X, Q61X)']}),(0,a.jsxs)("li",{children:[(0,a.jsx)("b",{children:"Zoldonrasib (RMC-9805)"}),', an oral, RAS(ON) mutant-selective inhibitor that is selective for the active or "(ON)" state of RAS G12D']}),(0,a.jsxs)("li",{children:[(0,a.jsx)("b",{children:"Elironrasib (RMC-6291)"}),', an oral, RAS(ON) mutant-selective inhibitor that is selective for the active or "(ON)" state of RAS G12C']}),(0,a.jsxs)("li",{children:[(0,a.jsx)("b",{children:"RMC-5127"}),', an oral, RAS(ON) mutant-selective inhibitor that is selective for the active or "(ON)" state of RAS G12V']})]})]})})}),(0,a.jsx)(x.B.Item.Root,{bleed:"none",id:"rason-inhibitor-clinical-trial-program",className:"bg-[#f5f8f9]! pt-24 pb-12",after:"bg-background",children:(0,a.jsxs)(x.B.Item.Subgrid,{xGridSpan:"full",children:[(0,a.jsx)("h2",{className:"text-[#1e6b5c]",children:"RAS(ON) Inhibitor Clinical Trial Locator"}),(0,a.jsx)(y.c,{marginTop:!1}),(0,a.jsx)(u,{}),(0,a.jsx)("h2",{className:"mt-[5rem] text-[#1e6b5c]",children:"RAS(ON) Inhibitor Clinical Trial Program"}),(0,a.jsx)(k,{trialData:R}),(0,a.jsx)(s.Suspense,{fallback:null,children:(0,a.jsx)(l.my,{})}),(0,a.jsxs)("p",{className:"text-xs",children:[(0,a.jsx)("sup",{children:"a"}),"This is not a complete list of eligibility criteria; for more information, please go to ClinicalTrials.gov. ",(0,a.jsx)("sup",{children:"b"}),"To view site-level status information, please go to ClinicalTrials.gov."]})]})}),(0,a.jsx)(x.B.Item.Root,{bleed:"none",id:"rason-inhibitor-clinical-trial-program",className:"-mb-8 bg-[#f5f8f9]! pt-0 pb-12",after:"bg-background",children:(0,a.jsxs)(x.B.Item.Subgrid,{xGridSpan:"full",children:[(0,a.jsx)("p",{children:"To potentially enroll in one of the above Revolution Medicines clinical trials, Patients should discuss with their doctor whether they qualify for one of the above Revolution Medicines clinical trials."}),(0,a.jsxs)("p",{children:[(0,a.jsxs)("span",{children:["These are select clinical trials only. To learn more about all our clinical trials, visit"," ",(0,a.jsx)(S,{className:"underline",href:"https://www.clinicaltrials.gov/search?spons=Revolution%20Medicines",children:"ClinicalTrials.gov"})]}),(0,a.jsx)("span",{children:". "}),"For questions on our clinical trials, please reach out to"," ",(0,a.jsx)("a",{href:"mailto:medinfo@revmed.com",className:"leading-7 underline",children:"medinfo@revmed.com"})," ","or"," ",(0,a.jsx)("a",{className:"text-nowrap",href:"tel:18442738633",children:"1-844-2-REVMED\xa0(1-844-273-8633)."})]}),(0,a.jsx)("p",{children:"The safety and efficacy of the agents and/or uses under investigation have not been established."})]})})]})}},54283:(e,t,r)=>{"use strict";r.d(t,{c:()=>s});var a=r(95155);let s=e=>{let{marginTop:t,variant:r="default",marginBottom:s=!0,className:l,...n}=e,i={default:{height:"h-[0.35rem]",color1:"bg-black",color2:"bg-[#d1dbd1]",width:"w-[8rem]"},thin:{height:"h-[0.13rem]",color1:"bg-black",color2:"bg-[#10B981]",width:"w-[5rem]"}};return(0,a.jsx)("div",{className:"relative ".concat(r?i[r].height:i.default.height," ").concat(r?i[r].color2:i.default.color2," ").concat(t?"mt-[3rem]":""," ").concat(s?"mb-[2rem]":""," ").concat(r?i[r].width:i.default.width," ").concat(l),...n,children:(0,a.jsx)("div",{className:"absolute h-full w-[50%] ".concat(r?i[r].color1:i.default.color1)})})}},63119:e=>{e.exports={"input-button":"DowndownMenu_input-button__PLsqr","input-button-disabled":"DowndownMenu_input-button-disabled__eKXUQ","dropdown-context":"DowndownMenu_dropdown-context__ux4QE",slideDownAndFade:"DowndownMenu_slideDownAndFade__t6ddj",slideUpAndFade:"DowndownMenu_slideUpAndFade__f_yyD","checkbox-container":"DowndownMenu_checkbox-container__agsri",checkbox:"DowndownMenu_checkbox__6lhWO","checkbox-label":"DowndownMenu_checkbox-label__qUteV"}},84873:(e,t,r)=>{"use strict";r.d(t,{E:()=>c});var a=r(95155),s=r(99708),l=r(74466);r(12115);var n=r(59434);let i=(0,l.F)("inline-flex items-center justify-center rounded-2xl border px-2 py-0.5 text-xs font-medium w-fit whitespace-nowrap shrink-0 [&>svg]:size-3 gap-1 [&>svg]:pointer-events-none focus-visible:border-ring focus-visible:ring-ring/50 focus-visible:ring-[3px] aria-invalid:ring-destructive/20 dark:aria-invalid:ring-destructive/40 aria-invalid:border-destructive transition-[color,box-shadow] overflow-hidden",{variants:{variant:{default:"border-transparent bg-primary text-primary-foreground [a&]:hover:bg-primary/90",secondary:"border-transparent bg-secondary text-secondary-foreground [a&]:hover:bg-secondary/90",destructive:"border-transparent bg-destructive text-white [a&]:hover:bg-destructive/90 focus-visible:ring-destructive/20 dark:focus-visible:ring-destructive/40 dark:bg-destructive/70",outline:"text-foreground [a&]:hover:bg-accent [a&]:hover:text-accent-foreground",tertiary:"text-tertiary-foreground bg-tertiary  [a&]:hover:bg-accent [a&]:hover:text-accent-foreground",muted:"text-muted-foreground bg-muted  [a&]:hover:bg-accent [a&]:hover:text-accent-foreground",accent:"text-accent-foreground bg-accent  [a&]:hover:bg-accent/90 [a&]:hover:text-accent-foreground",ghost:"bg-transparent text-foreground outline-none border-none"},size:{sm:"px-2 py-0.5 text-xs font-medium",md:"px-2 py-0.5 text-sm font-medium",lg:"px-4 py-1 text-lg font-medium"}},defaultVariants:{variant:"default"}});function c(e){let{className:t,variant:r,size:l,asChild:c=!1,...o}=e,d=c?s.DX:"span";return(0,a.jsx)(d,{"data-slot":"badge",className:(0,n.cn)(i({variant:r,size:l}),t),...o})}},92553:e=>{e.exports={container:"MapFilters_container__hOck3",button:"MapFilters_button__bwznm",selected:"MapFilters_selected__5g2Ts"}}},e=>{var t=t=>e(e.s=t);e.O(0,[880,37,278,473,125,722,945,582,977,816,441,684,358],()=>t(38450)),_N_E=e.O()}]);
